Center for Healthcare Economics & Policy

Our Economics team brings unique insights and advanced analytics from extensive experience on M&A transactions and competition issues across healthcare, life sciences and other industries. Expert solutions are offered for complex investigatory, transaction, regulatory and litigation matters. Our economic analyses inform expert testimony in the U.S. and internationally, supported by economic and industry research and advanced modeling, using extensive data sources.

Clients engage our expert team of antitrust, healthcare and industrial organization economists to provide economic testimony and privileged consulting in matters involving antitrust and competition issues — e.g., class certification, liability, market definition, and damages in antitrust and business disputes — including litigation and arbitration matters before U.S. and international dispute forums.

The pace of change in healthcare is unlike that of any other industry. Policies and regulations are constantly being proposed, implemented, and later amended to address issues of access, cost and quality. FTI Consulting’s Center for Healthcare Economics and Policy has the experience and expertise to estimate the impact of proposed as well as current policies on a complex and evolving healthcare system.

Because providers, insurers and governments operate in a dynamic healthcare environment, simple trend extrapolation may not suffice for sound predictions. The Center’s microsimulation models are appropriately detailed for economically sound estimates — able to assess change initiatives while explicitly accounting for changes in population, diversity and economic growth.

Economists from our Center for Healthcare Economics and Policy have expertise generating state-of-the-art HEOR evidence to support life sciences products commercialization.

Another specialty of the Center is bringing advanced analytics and industry expertise to help you solve your toughest challenges — for example, current and future demand, optimizing or reconfiguring system assets, and assessing outcomes and benefits from change. Our rigorous, proactive analyses of investments in technologies and facilities, as well as changes in services and capacity, help identify strategic choices, regulatory risks and benefits. Our experienced economists bring health-related expertise to address client needs across the healthcare and life sciences industry and as proven partners on work and regulatory reviews before U.S. and international agencies. By providing analysis of M&A and regulatory issues; market sizing; profitability analysis; and the creation of value propositions for healthcare products and services, accurate assessments in private equity can be made. We use evidence-based, comprehensive analysis of a population’s health and utilization to inform strategic healthcare transformation and interventions.

Improving the health of local populations requires evidence-based strategies to address the economic and health impacts of chronic disease conditions. Our cutting-edge modeling informs the extent of chronic health burdens and improves the efficacy of interventions aimed at reducing them. Our Economic team applies advanced methods to assist you in your community health action reviews, as well as advanced analytics to quantify economic impact and community benefit.